You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
|
|---|---|
| Published in |
Journal of Clinical Oncology, September 2019
|
| DOI | 10.1200/jco.19.00739 |
| Pubmed ID | |
| Authors |
R. Wendel Naumann, Antoine Hollebecque, Tim Meyer, Michael-John Devlin, Ana Oaknin, Joseph Kerger, Jose M. López-Picazo, Jean-Pascal Machiels, Jean-Pierre Delord, Thomas R.J. Evans, Valentina Boni, Emiliano Calvo, Suzanne L. Topalian, Tian Chen, Ibrahima Soumaoro, Bin Li, Junchen Gu, Ricardo Zwirtes, Kathleen N. Moore |
X Demographics
The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 33% |
| United Kingdom | 2 | 8% |
| Australia | 1 | 4% |
| Saudi Arabia | 1 | 4% |
| Peru | 1 | 4% |
| Mexico | 1 | 4% |
| Brazil | 1 | 4% |
| Germany | 1 | 4% |
| Italy | 1 | 4% |
| Other | 2 | 8% |
| Unknown | 5 | 21% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 58% |
| Practitioners (doctors, other healthcare professionals) | 8 | 33% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
| Scientists | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 218 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 218 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 20 | 9% |
| Other | 19 | 9% |
| Researcher | 19 | 9% |
| Student > Master | 17 | 8% |
| Student > Ph. D. Student | 15 | 7% |
| Other | 38 | 17% |
| Unknown | 90 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 69 | 32% |
| Biochemistry, Genetics and Molecular Biology | 18 | 8% |
| Agricultural and Biological Sciences | 7 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 2% |
| Nursing and Health Professions | 3 | 1% |
| Other | 14 | 6% |
| Unknown | 103 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 90. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 January 2023.
All research outputs
#470,027
of 25,385,509 outputs
Outputs from Journal of Clinical Oncology
#957
of 22,054 outputs
Outputs of similar age
#9,843
of 350,585 outputs
Outputs of similar age from Journal of Clinical Oncology
#15
of 179 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,054 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,585 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 179 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.